Samyukta Mullangi 5.0 1 idea

Oncologist, Vice President of Clinical Strategy, OpenEvidence
Not enough evaluated ideas yet
By sector
ETF
1 ideas
Top tickers (by frequency)
XLV 1 ideas
The speaker, an oncologist working with an AI medical chatbot company, explicitly states AI tools will become part of clinical practice but will not replace physicians. Adoption is constrained by unresolved issues of legal liability, algorithmic hallucination/bias, and the need for a human to assume ultimate responsibility for patient outcomes. WATCH because integration will be slow and contentious, focusing on augmentation. Companies making grandiose replacement claims are deflecting liability, indicating a major barrier to scalability and profitability. A high-profile failure causing patient harm could lead to stringent regulation that drastically slows adoption and impacts the valuation of companies in the space.
XLV Bloomberg Markets Mar 21, 14:00
Oncologist, Vice President...
Samyukta Mullangi (Oncologist, Vice President of Clinical Strategy, OpenEvidence) | 1 trade ideas tracked | XLV | YouTube | Buzzberg